Skip to main content
SpringerLink
Log in

Pathophysiology: Clinical Spectrum and Current Management

  • Chapter
  • First Online:
Management of Heart Failure

  • 1161 Accesses

Abstract

The noted biological and medical writer Lewis Thomas mused in his 1983 essay, entitled ‘The Artificial Heart:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lewis T. Late Night Thoughts on Listening to Mahler’s Ninth Symphony, Viking Press: Penguin. New York City, 1983. ISBN 0-670-70390-7.

    Google Scholar 

  2. Willerson JT, Delgado III R, Mann D. Treating relentlessly progressive congestive heart failure: what next? Tex Heart Inst J. 1998;25:235–7.

    PubMed Central  CAS  PubMed  Google Scholar 

  3. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998;97:282–9.

    Article  CAS  PubMed  Google Scholar 

  4. Willerson JT. Other cardiomyopathies. In: Willerson JT, Cohn JN, editors. Cardiovascular medicine. New York: Churchill Livingstone; 1995. p. 888–94.

    Google Scholar 

  5. Luppi P, Rudert WA, Zanone MM, Stassi G, Finegold D, et al. Idiopathic dilated cardiomyopathy: a super-antigen driven autoimmune disease. Circulation. 1998;98:777–85.

    Article  CAS  PubMed  Google Scholar 

  6. Cohn JN. Overview of pathophysiology of clinical heart failure. In: Hosenpud JD, Greenberg BH, editors. Congestive heart failure: pathophysiology, diagnosis and comprehensive approach to management. New York: Springer; 1994. p. 11–6.

    Chapter  Google Scholar 

  7. Katz AM. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med. 1994;121:363–71.

    Article  CAS  PubMed  Google Scholar 

  8. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, et al. Left ventricular remodelling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693–702.

    Article  CAS  PubMed  Google Scholar 

  9. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Pro-inflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201–6.

    Article  CAS  PubMed  Google Scholar 

  10. Haywood GA, Tsao PS, von der Leyden HE, Mann MJ, Keeling PJ, Trindade PT, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087–94.

    Article  CAS  PubMed  Google Scholar 

  11. Oral J, Kapadia S, Nakano M, Torre-Amione G, Lee J, Lee-Jackson D, et al. Tumour necrosis factor-alpha and the failing human heart. Clin Cardiol. 1995;18 Suppl 4:IV20–7.

    CAS  PubMed  Google Scholar 

  12. Li G, Willerson JT. Molecular biologic alterations in heart failure. In: Frazier OH, editor. Support and replacement of the failing heart. Philadelphia: Linppincott-Raven; 1996. p. 69–74.

    Google Scholar 

  13. Anversa P, Kajstura J, Olivetti M. Myocyte death in heart failure. Curr Opin Cardiol. 1996;11:245–51.

    Article  CAS  PubMed  Google Scholar 

  14. Hosenpud JD, Greenberg BH, editors. Congestive heart failure: pathophysiology, diagnosis and comprehensive approach to management. New York: Springer; 1994. p. 623–4.

    Google Scholar 

  15. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med. 1992;117:502–10.

    Article  CAS  PubMed  Google Scholar 

  16. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565–74.

    Article  CAS  PubMed  Google Scholar 

  17. Willerson JT, Cohn JN, editors. Cardiovascular medicine. New York: Churchill-Livingstone; 1995. p. 952–3.

    Google Scholar 

  18. Benedict CR. Neurohumoral aspects of heart failure. Cardiol Clin. 1994;12:9–23.

    CAS  PubMed  Google Scholar 

  19. Hosenpud JD, Greenberg BH, editors. Congestive heart failure: pathophysiology, diagnosis and comprehensive approach to management. New York: Springer; 1994. p. 13–4.

    Google Scholar 

  20. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.

    Article  CAS  PubMed  Google Scholar 

  21. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler M. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation. 1993;88:136–45.

    Article  CAS  PubMed  Google Scholar 

  22. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, et al. Endothelin in human congestive heart failure. Circulation. 1994;89:1580–6.

    Article  CAS  PubMed  Google Scholar 

  23. Lefkowitz RJ. A Brief History of G-Protein Coupled Receptors (Nobel Lecture). Angewandte Chemie International Edition. First published: 6 May 2013. DOI:10.1002/anie.201301924.

    Google Scholar 

  24. Mestroni L, Giacca M. Molecular genetics of dilated cardiomyopathy. Curr Opin Cardiol. 1997;12:203–9.

    Article  Google Scholar 

  25. Towbin JA, Hejtmancik JF, Brink A, et al. X-linked dilated cardiomyopathy: molecular genetic evidence of the Duchenne muscular dystrophy (dystrophin) gene at Xp21 locus. Circulation. 1993;87:1854–65.

    Article  CAS  PubMed  Google Scholar 

  26. Garcia-Pavia P1, Cobo-Marcos M, Guzzo-Merello G, Gomez-Bueno M, Bornstein B, Lara-Pezzi E, Segovia J, Alonso-Pulpon L. Genetics in dilated cardiomyopathy. Biomark Med. 2013;7(4):517–33. doi:10.2217/bmm.13.77.

    Article  CAS  PubMed  Google Scholar 

  27. Marsiglia JD, Pereira AC. Hypertrophic cardiomyopathy: how do mutations lead to disease? Arq Bras Cardiol. 2014;102(3):295–304.

    PubMed Central  CAS  PubMed  Google Scholar 

  28. Hultgårdh-Nilsson A, Durbeej M. Role of the extracellular matrix and its receptors in smooth muscle cell function: implications in vascular development and disease. Curr Opin Lipidol. 2007;18(5):540–5.

    Article  PubMed  Google Scholar 

  29. Tromp J, van der Pol A, Klip IT, de Boer RA, Jaarsma T, van Gilst WH, Voors AA, van Veldhuisen DJ, van der Meer P. The fibrosis marker syndecan-1 and outcome in heart failure patients with reduced and preserved ejection fraction. Circ Heart Fail. 2014;7(3):457–62.

    Article  CAS  PubMed  Google Scholar 

  30. Cintron G, Bigas C, Linares E, Aranda JM, Hernandez E. Nurse practitioner role in a chronic congestive heart failure clinic. In hospital time, costs and past satisfaction. Heart Lung. 1983;12:237–40.

    CAS  PubMed  Google Scholar 

  31. Rich MW, Beckman V, Wittenber C, Level CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;33:1190–5.

    Article  Google Scholar 

  32. Smith LE, Fabri SA, Pai R, Ferry D, Heywood T. Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic. Clin Cardiol. 1997;20:949–54.

    Article  CAS  PubMed  Google Scholar 

  33. Shepherd J, Cobbe SM, Ford I, Isler CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–7.

    Article  CAS  PubMed  Google Scholar 

  34. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S). Lancet. 1994;344:1382–9.

    Article  Google Scholar 

  35. Squires RW, Lavie CJ, Brandt TR, Gau GT, Bailey KR. Cardiac rehabilitation in patients with severe left ventricular dysfunction. Mayo Clin Proc. 1987;62:997–1002.

    Article  CAS  PubMed  Google Scholar 

  36. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:523–33.

    Google Scholar 

  37. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, for the PROMISE Study Research Group, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:1468–75.

    Article  CAS  PubMed  Google Scholar 

  38. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans’ administration co-operative study. N Engl J Med. 1986;314:1547–52.

    Article  CAS  PubMed  Google Scholar 

  39. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani G, Smith R, Dunken B, Loeb H, Wong M, Bhat G, Goldman S, et al. A comparison of enalapril with hydralazine-isosorbide nitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303–10.

    Article  CAS  PubMed  Google Scholar 

  40. The Multi-center Diltiazem Post-infarction Research Group. The effect of diltiazem on mortality and re-infarction after myocardial infarction. N Engl J Med. 1988;319:385–92.

    Article  Google Scholar 

  41. Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL, for the Prospective Randomized Amlodipine Survival Evaluation Study. Effect of Amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107–14.

    Article  CAS  PubMed  Google Scholar 

  42. Packer M, Bristow MR, Cohn JN, Colussci WS, Fowler MB, Gilbert EM, Shusterman NH, for the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–55.

    Google Scholar 

  43. Australia/New Zealand Heart Failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 1997;349:375–80.

    Article  Google Scholar 

  44. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, on behalf of the SAVE Investigators, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669–77.

    Article  CAS  PubMed  Google Scholar 

  45. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–91.

    Article  Google Scholar 

  46. Westaby S, Coats AFS. Mechanical bridge to recovery. Eur Heart J. 1998;19:541–7.

    Article  CAS  PubMed  Google Scholar 

  47. Schmid C, Hammel D, Deng MC, Weyand M, Baba H, Tjan TDT, Drees G, Roeder N, Schmidt C, Scheld HH. Ambulatory care of patients with left ventricular assist devices. Circulation. 1999;100(Suppl II):II-224–8.

    CAS  Google Scholar 

  48. Mueller J, Wallukut G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theoderis V, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;95:542–9.

    Article  Google Scholar 

  49. Schmid C, Weyand M, Hammel D, Deng MC, Nabavi D, Scheld HH. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg. 1998;65:1703–10.

    Article  CAS  PubMed  Google Scholar 

  50. Levin H, Chen J, Oz M, Catanese K, Krum H, Goldsmith R, Packer M, Rose E. Potential for left ventricular assist devices as outpatient therapy with awaiting transplantation. Ann Thorac Surg. 1994;58:1515–20.

    Article  CAS  PubMed  Google Scholar 

  51. Pette D, Smith ME, Staudte HW, et al. Effects of long-term electrical stimulation on some contractile and metabolic characteristics of fast rabbit muscles. Pflügers Arch. 1973;338:257–61.

    Article  CAS  PubMed  Google Scholar 

  52. Chachques JC, Grandjean PA, Carpentier A. Dynamic cardiomyoplasty: experimental cardiac wall replacement with a stimulated skeletal muscle. In: Chiu RC-J, editor. Bio-mechanical cardiac assist: cardiomyoplasty and muscle-powered devices. Mt Kisco: Futura Publsishin Co; 1986. p. 59–84.

    Google Scholar 

  53. Chiu RC-J, Walsh GL, Dewar ML, et al. Implantable extra-aortic balloon assist powered by transformed fatigue-resistant skeletal muscle. J Thorac Cardiovasc Surg. 1987;94:694–8.

    CAS  PubMed  Google Scholar 

  54. Magovern JA, Furnary AP, Christlieb IY, Kao RL, Park SB, Magovern GJ. Indications and risk analysis for clinical cardiomyoplasty. Semin Thorac Cardiovasc Surg. 1991;3(2):145–8.

    CAS  PubMed  Google Scholar 

  55. Young JB, Kirklin JB. Cardiomyoplasty-Skeletal Muscle Assist Randomized Trial (C-SMART): 6 month results. Circulation. 1999;100(18 Suppl I):514.

    Google Scholar 

  56. Bolling SF, Deeb GM, Brunsting LA, et al. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 1995;104:676–83.

    Article  Google Scholar 

  57. Bishay ES, McCarthy PM, Cosgrove DM, Hoercher KJ, Smedira NG, Mukherjee D, White J, Blackstone EH. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2000;17:213–21.

    Article  CAS  PubMed  Google Scholar 

  58. Batista RJV, Nery P, Bocchino L, et al. Partial left ventriculectomy to treat end stage heart disease. Ann Thorac Surg. 1997;64:634–8.

    Article  CAS  PubMed  Google Scholar 

  59. Dowling RD, Koenig SC, Ewert DL, Cerrito P, Laureao MA, Gray LA. Does partial left ventriculectomy improve left ventricular systolic and diastolic function? Circulation. 1999;100(18 Suppl 1):801.

    Google Scholar 

  60. Starling RC, McCarthy PM, Hoercher KJ, Buda T, Goormastic M, Young JB. Partial left ventriculectomy for dilated cardiomyopathy: a viable option for end-stage heart failure? Circulation. 1999;100(18 Suppl 1):801.

    Google Scholar 

  61. Reddy SB, Cooley DA, Duncan JM, et al. Left ventricular aneurysm: twenty-year surgical experience with 1572 patients at the Texas Heart Institute. Cardiovasc Dis Bull Tex Heart Inst. 1981;11:165–86.

    Google Scholar 

  62. Kesler KA, Fiore AC, Naunheim KS. Anterior wall ventricular aneurysm repair: a comparison of linear versus circular closure. J Thorac Cardiovasc Surg. 1992;103:841–8.

    CAS  PubMed  Google Scholar 

  63. Jatene AD. Surgical treatment of left ventricular aneurysm. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, editors. Glenn’s Thoracic and Cardiovascular Surgery 6th ed. Vol 2. Connecticut: Appleton & Lange; 1996. p. 1829–36.

    Google Scholar 

  64. DiDonato M, D’Or V, Sabatier M, Montiglio F, et al. Outcome of left ventricular aneurysmectomy with patch repair in patients with severely depressed pump function. Am J Cardiol. 1995;76:557–61.

    Article  CAS  Google Scholar 

  65. Cox JL Surgical management of left ventricular aneurysms by the Jatene technique. Oper Tech Card Thoracic Surg Comp Atlas. In: Cox JL, Sundt TL, editors. WB Saunders; 1997;2(2):132–8.

    Google Scholar 

  66. D’Or V, Sabatier M, DiDonato M, et al. Late hemodynamic results after left ventricular patch repair associated with coronary grafting in patients with post-infarction akinetic or dyskinetic aneurysm of the left ventricle. J Thorac Cardiovasc Surg. 1995;110:1291–301.

    Article  Google Scholar 

  67. D’Or V. Reconstructive left ventricular surgery for post-ischemic akinetic dilatation. Semin Thorac Cardiovasc Surg. 1997;9(2):139–45.

    Google Scholar 

  68. Klein M, Herman M, Gorlin R. A hemodynamic study of left ventricular aneurysms. Circulation. 1967;35:614–30.

    Article  CAS  PubMed  Google Scholar 

  69. D’Or V. The treatment of refractory ischemic ventricular tachycardia by endo-ventricular patch plasty reconstruction of the left ventricle. Semin Thorac Cardiovasc Surg. 1997;9(2):146–55.

    Google Scholar 

  70. Judd RM, Kim RJ, Chen E-L, Fieno DS, Rehwald WG, Lomasney JW, Simonetii OP, Kasper JM, Schwartzman PR, McCarthy PM, Smedira NG, White RD. Contrast enhanced magnetic resonance imaging defines the pre-operative location and extent of myocardial scar prior to the D’Or procedure. Circulation. 1999;100(18 Suppl 1):798.

    Google Scholar 

  71. Buckberg GD. Defining the relationship between akinesia and dyskinesia and the cause of left ventricular failure after anterior infarction and reversal of remodelling to restoration. J Thorac Cardiovasc Surg. 1998;116:47–9.

    Article  CAS  PubMed  Google Scholar 

  72. Raman J, Dixit A, Storer M, Hare DL, Buxton BF. Geometric endo-ventricular patch repair of inferior left ventricular scars improves mitral regurgitation and clinical outcome. Ann Thorac Surg. 2001;72:1055–8.

    Article  Google Scholar 

  73. Dabol R, Edwards NM. Cardiac transplantation and other therapeutic options in the treatment of end-stage heart disease. Compr Ther. 2000;26:109–13.

    Article  CAS  PubMed  Google Scholar 

  74. Krum H, on behalf of the National Heart Foundation of Australia Chronic Heart Failure Clinical Practice Guidelines Writing Panel. Guidelines for management of patients with chronic heart failure in Australia. Med J Aust. 2001;174:459–66.

    CAS  PubMed  Google Scholar 

  75. Barold SS. Biventricular cardiac pacing: promising new therapy for congestive heart failure. Chest. 2000;118:1812–9.

    Article  Google Scholar 

  76. Hauer RN, Aliot E, Block M, et al. Indications for implantable cardioverter-defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on arrhythmias of European society of cardiology. Eur Heart J. 2001;22:1074–81.

    Article  CAS  PubMed  Google Scholar 

  77. Adamopoulos S, Coats A, Brunotte F, Arnolda L, Meyer T, Thompson C, Dunn J, Stratton J, Kemp G, Radda G, Rajagopalan B. Physical training improves skeletal muscle metabolism in chronic heart failure. J Am Coll Cardiol. 1993;21:1101–6.

    Article  CAS  PubMed  Google Scholar 

  78. Hare DL, Ryan TM, Selig SE, Pellizzer A, Wrigley TV, Krum H. Resistance exercise training increases muscle strength, endurance and blood flow in patients with chronic heart failure. Am J Cardiol. 1999;83:1674–7.

    Article  CAS  PubMed  Google Scholar 

  79. McKelvie RS, Mccartney N, Tomlinson C, Baier R, MacDougall JD. Comparison of hemodynamic responses to cycling and resistance exercise in congestive heart failure secondary to ischemic cardiomyopathy. Am J Cardiol. 1995;76:977–9.

    Article  CAS  PubMed  Google Scholar 

  80. Honig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation. 1996;93:210–4.

    Article  Google Scholar 

  81. Katz SD, Yuen J, Bijou R, LeJemtel TH. Training improves endothelium-dependent vasodilatation in resistance vessels of patients with heart failure. J Appl Physiol. 1997;82:1488–92.

    Article  CAS  PubMed  Google Scholar 

  82. Copuya ER, Gerber RS, Drinkwater DJ, Laks H, et al. Girdling effects of non-stimulated cardiomyoplasty on left ventricular function. Ann Thorac Surg. 1993;56:867–70.

    Article  Google Scholar 

  83. Patel HJ, Polidori DJ, Pila JJ, Kass DA, et al. Stabilisation of chronic remodelling by asynchronous cardiomyoplasty in dilated cardiomyopathy: effects of a conditioned muscle wrap. Circulation. 1997;96:3665–71.

    Article  CAS  PubMed  Google Scholar 

  84. Vaynbalt M, Chiavarelli M, Shah HR, et al. Cardiac binding in experimental heart failure. Ann Thorac Surg. 1997;64:81–5.

    Article  Google Scholar 

  85. Raman J, Power JM, Buxton BF. Ventricular containment as an adjunct to conventional cardiac surgery. Ann Thorac Surg. 2000;70(3):1124–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Chicago, Chicago, IL, USA

    Mahesh P. Gupta PhD

  2. Cardiovascular & Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA

    Jaishankar Raman MBBS, MMed, FRACS, PhD

Authors
  1. Mahesh P. Gupta PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaishankar Raman MBBS, MMed, FRACS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaishankar Raman MBBS, MMed, FRACS, PhD .

Editor information

Editors and Affiliations

  1. Cardiovascular & Thoracic Surgery, Rush University Medical Center, Chicago, USA

    Jai Raman

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag London Ltd.

About this chapter

Cite this chapter

Gupta, M.P., Raman, J. (2016). Pathophysiology: Clinical Spectrum and Current Management. In: Raman, J. (eds) Management of Heart Failure. Springer, London. https://doi.org/10.1007/978-1-4471-4279-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4279-9_2

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4278-2

  • Online ISBN: 978-1-4471-4279-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation